RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Food and Drug Administration

A collection of news and information related to Food and Drug Administration published by this site and its partners.

Top Food and Drug Administration Articles

Displaying items 67-77
  • Five Questions for Michael Treuth of J.W. Treuth & Sons

    Five Questions for Michael Treuth of J.W. Treuth & Sons
    J.W. Treuth & Sons has been nestled in Oella so long, Michael Treuth said no one can figure out quite when the family-owned slaughterhouse and butcher shop first opened its doors, though a sign out front boasts more than 100 years in the business. The...
  • Haagen-Dazs ice cream recalled

    Haagen-Dazs ice cream recalled
    Nestle USA is recalling 10,000 packages of chocolate peanut butter ice cream that were incorrectly labeled as another flavor, putting consumers with peanut allergies at risk, the company said. A customer complaint resulted in the recall of packages...
  • State Senate panel approves medical marijuana bill

    State Senate panel approves medical marijuana bill
    HARRISBURG — As teary-eyed parents cradling ill children watched, a state Senate committee on Friday passed a landmark bill that could make medical marijuana legal in Pennsylvania. But the bipartisan bill still has a long way to go before becoming...
  • New Berger cookie label, but same old cookie

    New Berger cookie label, but same old cookie
    There's nothing different about your Berger cookie. It's just the nutritional label that's changed. A sharp-eyed shopper wrote in to tell us that he had tried the Berger cookie that has 0 grams of trans fat, and that it tasted just as good as the 1-gram...
  • Inhaled insulin drug Afrezza, from L.A.'s MannKind, is approved

    Inhaled insulin drug Afrezza, from L.A.'s MannKind, is approved
    Los Angeles billionaire inventor Alfred Mann's almost decade-long quest to develop an inhalable form of insulin for diabetics won approval Friday from U.S. regulators. His Valencia company, MannKind Corp., got the OK to sell the drug called Afrezza,...
  • $50 million or more pledged to fight blindness

    $50 million or more pledged to fight blindness
    Gordon Gund is the CEO of a venture capitalist fund, the former principal owner of the Cleveland Cavaliers and a member of the Kellogg Co.'s board of directors. He has also been blind for more than 40 years. On Saturday, Gund announced that his family...
  • U.S. regulator approves Afrezza inhalable insulin

    U.S. regulator approves Afrezza inhalable insulin
    After more than a decade of work and nearly $1 billion of his personal fortune, Los Angeles inventor Alfred Mann's quest to develop an inhalable form of insulin for people with diabetes won approval Friday from U.S. regulators. His company, MannKind...
  • Leukemia patient sues Trader Joe's, supplier over infection

    Leukemia patient sues Trader Joe's, supplier over infection
    A cancer patient who shopped at a Northbrook Trader Joe’s is suing the grocer and one its suppliers, saying it sold him tainted food that was later recalled and caused a bacterial infection. Vladimir Sokhatskiy alleges in the lawsuit filed...
  • FDA clears device that lets paraplegics walk again

    FDA clears device that lets paraplegics walk again
    A device designed by a quadriplegic Israeli entrepreneur to increase his own mobility, and in use already to get wounded U.S. military personnel up and walking again, has won clearance from the Food and Drug Administration for broad marketing in the...
  • E-cigarette chain MadVapes hitches a ride on industry's success

    Starting a multimillion-dollar company wasn't what Mark Hoogendoorn intended. He just wanted to quit smoking. The computer programmer had tried it all: nicotine patches, nicotine gum, hypnosis. He didn't want his teenage son and daughter to see him...
  • Illinois among 45 states settling off-label dispute with GlaxoSmithKline

    Illinois among 45 states settling off-label dispute with GlaxoSmithKline
    The Illinois Attorney General on Wednesday announced the state was part of a $105 million settlement with GlaxoSmithKline LLC to resolve allegations that the company unlawfully promoted its asthma drug Advair and antidepressants Paxil and Wellbutrin....